Pliant Therapeutics (NASDAQ:PLRX) Receives “Neutral” Rating from HC Wainwright
Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “neutral” rating reiterated by research analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. Several other equities analysts also recently weighed in on the company. JPMorgan Chase & Co. downgraded Pliant Therapeutics from an “overweight” rating to a “neutral” rating […]
Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “neutral” rating reiterated by research analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. Several other equities analysts also recently weighed in on the company. JPMorgan Chase & Co. downgraded Pliant Therapeutics from an “overweight” rating to a “neutral” rating […]
